跳至主要内容
临床试验/CTRI/2026/07/113534
CTRI/2026/07/113534招募中不适用

A Clinical Study to Evaluate the Antihypertensive Effect of Ayurvedic Formulations Bpgrit with Mukta vati Extra Power in the Management of Hypertension: Prospective, open label, single arm study - NIL

Patanjali Research Foundation0 个研究点目标入组 92 人开始时间: 2026年7月22日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
92

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Blood pressure ranging between 130/80 to 180/120 mmHg
  • The subject is able and willing to provide consent

排除标准

  • Alcohol-associated liver disease (ALD) engage in heavy drinking about 4 or more drinks per day or 8 or more drinks per week for women and 5 or more drinks per day or 15 or more drinks per week for men and other causes of liver disease.
  • Patients with uncontrolled diabetes mellitus HbA1C more tha equal to 7%, hepatic or renal failure.
  • Patients with expected pregnancy or breastfeeding.
  • History of angina pectoris, myocardial infarction or stroke were excluded from the study.
  • Patient not willing to give written informed consent.

研究者

相似试验

Effect of Ayurvedic Formulations Bpgrit with Mukta... | 临床试验